|
1
|
da Costa AABA and Baiocchi G: Genomic
profiling of platinum-resistant ovarian cancer: The road into
druggable targets. Semin Cancer Biol. 2020:30221–30222. 2020.
|
|
2
|
Kujawa KA and Lisowska KM: Ovarian
cancer-from biology to clinic. Postepy Hig Med Dosw (Online).
69:1275–1290. 2015.(In Polish). View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Skoda AM, Simovic D, Karin V, Kardum V,
Vranic S and Serman L: The role of the hedgehog signaling pathway
in cancer: A comprehensive review. Bosn J Basic Med Sci. 18:8–20.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang F, Ma L, Zhang Z, Liu X, Gao H,
Zhuang Y, Yang P, Kornmann M, Tian X and Yang Y: Hedgehog signaling
regulates epithelial-mesenchymal transition in pancreatic cancer
stem-like cells. J Cancer. 7:408–417. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun M, Zhang N, Wang X, Li Y, Qi W, Zhang
H, Li Z and Yang Q: Hedgehog pathway is involved in nitidine
chloride induced inhibition of epithelial-mesenchymal transition
and cancer stem cells-like properties in breast cells. Cell Biosci.
6:442016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu Y, Song S, Wang Z and Ajani JA: The
role of hedgehog signaling in gastric cancer: Molecular mechanisms,
clinical potential, and perspective. Cell Commun Signal.
17:1572019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Levanat S, Sabol M, Musani V, Ozretic P
and Trnski D: Hedgehog signaling pathway as genetic and epigenetic
target in ovariantumors. Curr Pharm. 23:73–94. 2017.
|
|
8
|
Coffman LG, Choi YJ, McLean K, Allen BL,
di Magliano MP and Buckanovich RJ: Human carcinoma-associated
mesenchymal stem cells promote ovarian cancer chemotherapy
resistance via a BMP4/HH signaling loop. Oncotarget. 7:6916–6932.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Christensen ST and Ott CM: Cell signaling:
A ciliary signaling switch. Science. 317:330–331. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Blotta S, Jakubikova J, Calimeri T,
Roccaro AM, Amodio N, Azab AK, Foresta U, Mitsiades CS, Rossi M,
Todoerti K, et al: Canonical and noncanonical hedgehog pathway in
the pathogenesis of multiple nyeloma. Blood. 120:5002–5013. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song X, Yan L, Lu C, Zhang C, Zhu F, Yang
J, Jing H, Zhang Y, Qiao J and Guo H: Activation of hedgehog
signaling and its association with cisplatin resistance in ovarian
epithelial tumors. Oncol Lett. 15:5569–5576. 2018.PubMed/NCBI
|
|
12
|
Steg AD, Burke MR, Amm HM, Katre AA,
Dobbin ZC, Jeong DH and Landen CN: Proteasome inhibition reverses
hedgehog inhibitor and taxane resistance in ovarian cancer.
Oncotarget. 5:7065–7080. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Steg AD, Bevis KS, Katre AA, Ziebarth A,
Dobbin ZC, Alvarez RD, Zhang K, Conner M and Landen CN: Stem cell
pathways contribute to clinical chemoresistance in ovarian cancer.
Clin Cancer Res. 18:869–881. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu SS and Cirillo N: The molecular markers
of cancer stem cells in head and neck tumors. J Cell Physiol.
235:65–73. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cao J, Zhao M, Liu J, Zhang X, Pei Y, Wang
J, Yang X, Shen B and Zhang J: RACK1 promotes self-renewal and
chemoresistance of cancer stem cells in human hepatocellular
carcinoma through stabilizing nanog. Theranostics. 9:811–828. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kakiuchi S, Minami Y, Miyata Y, Mizutani
Y, Goto H, Kawamoto S, Yakushijin K, Kurata K, Matsuoka H and
Minami H: NANOG expression as a responsive biomarker during
treatment with hedgehog signal inhibitor in acute myeloid leukemia.
Int J Mol Sci. 18:4862017. View Article : Google Scholar
|
|
17
|
Servo SF, Scully RE and Subin LH:
Histologic typing of ovarian tumors. WHO Geneva. 42–45. 1973.
|
|
18
|
Pecorelli S: Revised FIGO staging for
carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol
Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Remmele W and Stegner HE: Recommendation
for uniform definition of an immunoreactive score (IRS) for
immunohistochemical estrogen receptor detection (ER-ICA) in breast
cancer tissue. Pathologe. 8:138–140. 1987.(In German). PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kubo M, Nakamura M, Tasaki A, Yamanaka N,
Nakashima H, Nomura M, Kuroki S and Katano M: Hedgehog signaling
pathway is a new therapeutic target for patients with breast
cancer. Cancer Res. 64:6071–6074. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feng YZ, Shiozawa T, Miyamoto T, Kashima
H, Kurai M, Suzuki A, Ying-Song J and Konishi I: Overexpression of
hedgehog signaling molecules and its involvement in the
proliferation of endometrial carcinoma cells. Clin Cancer Res.
13:1389–1398. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ozretić P, Trnski D, Musani V, Maurac I,
Kalafatić D, Orešković S, Levanat S and Sabol M: Non-canonical
hedgehog signaling activation in ovarian borderline tumors and
ovarian carcinomas. Int J Oncol. 51:1869–1877. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rokkam P, Gugalavath S, Gift Kumar DK,
Vempati RK and Malla RR: Prognostic role of hedgehog GLI1 signaling
pathway in aggressive and metastatic breast cancers. Curr Drug
Metab. 21:33–43. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang C, Cheng L, Song S, Wu S and Sun G:
Gli1 interacts with YAP1 to promote tumorigenesis in esophageal
squamous cell carcinoma. J Cell Physiol. 235:8224–8235. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ciucci A, De Stefano I, Vellone VG, Lisi
L, Bottoni C, Scambia G, Zannoni GF and Gallo D: Expression of the
glioma-associated oncogene homolog 1 (gli1) in advanced serous
ovarian cancer is associated with unfavorable overall survival.
PLoS One. 8:e601452013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schreiber L, Raanan C and Amsterdam A:
CD24 and Nanog identify stem cells signature of ovarian epithelium
and cysts that may develop to ovarian cancer. Acta Histochem.
116:399–406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sabol M, Trnski D, Uzarevic Z, Ozretic P,
Musani V, Rafaj M, Cindric M and Levanat S: Combination of
cyclopamine and tamoxifen promotes survival and migration of mcf-7
breast cancer cells-interaction of hedgehog-gli and estrogen
receptor signaling pathways. PLoS One. 9:e1145102014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma Y, Yu W, Shrivastava A, Alemi F,
Lankachandra K, Srivastava RK and Shankar S: Sanguinarine inhibits
pancreatic cancer stem cell characteristics by inducing oxidative
stress and suppressing sonic hedgehog-Gli-Nanog pathway.
Carcinogenesis. 38:1047–1056. 2017. View Article : Google Scholar : PubMed/NCBI
|
